Cargando…

ASH Registry Offers Insights on COVID‐19 in Patients with Hematologic Malignancies

For patients with blood cancers, the COVID‐19 mortality rate is approximately 20% overall and 33% for those who require hospitalization, according to new data from the ASH Research Collaborative COVID‐19 Registry for Hematology.

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Conference Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869116/ https://www.ncbi.nlm.nih.gov/pubmed/33368829 http://dx.doi.org/10.1002/onco.13657

Ejemplares similares

Registry Study Describes COVID‐19 Mortality and Hospitalization in Patients with Breast Cancer
Publicado: (2021)

Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies
por: Einsele, Hermann, et al.
Publicado: (2020)

Genomic Stratification of Hematological Malignancies
por: Robbe, Pauline, et al.
Publicado: (2023)

Outcomes of patients with hematologic malignancies and COVID-19 from the Hematologic Cancer Registry of India
por: Jain, Arihant, et al.
Publicado: (2022)

Risks for Hospitalization and Death Among Patients with Blood Disorders from the ASH RC COVID-19 Registry for Hematology
por: Hicks, Lisa K., et al.
Publicado: (2021)

Cellular immunotherapy as a beacon of hope for hematological malignancies
por: Lee, Hyun-Ju, et al.
Publicado: (2015)

Chimeric antigen T cell receptor treatment in hematological malignancies
por: Ali, Natasha
Publicado: (2019)

The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies
por: Einsele, Hermann, et al.
Publicado: (2021)

Breast Cancer Chemotherapy Can Be Administered Safely During the COVID‐19 Pandemic
Publicado: (2021)

Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub
por: Wood, William A., et al.
Publicado: (2020)

What insights can fMRI offer into the structure and function of mid-tier visual areas?
por: OLMAN, CHERYL A.
Publicado: (2015)

Covid-19 Infection in Hematological Malignancies: Registry Data from India
por: Jain, Arihant, et al.
Publicado: (2021)

What opportunities could the COVID-19 outbreak offer for sustainability transitions research on electricity and mobility?
por: Kanda, Wisdom, et al.
Publicado: (2020)

Outcomes of Patients with Hematologic Malignancies and COVID-19 Infection: A Report from the ASH Research Collaborative Data Hub
por: Wood, William A., et al.
Publicado: (2020)

Overview of the Side-Effects of FDA- and/or EMA-Approved Targeted Therapies for the Treatment of Hematological Malignancies
por: Constantinescu, Catalin, et al.
Publicado: (2020)

A multifaceted approach targeting NK cells for better treatment of cancer: focus on hematological malignancies
por: Kim, Hun Sik
Publicado: (2015)

Mucositis and Infection in Hematology Patients
por: Blijlevens, Nicole M. A., et al.
Publicado: (2023)

Rising from the Ashes: DNA Repair in Deinococcus radiodurans
por: Cox, Michael M., et al.
Publicado: (2010)

Coronavirus disease-19 and its hematological manifestations
por: Kim, Hye-Ran, et al.
Publicado: (2020)

COVID-19 in patients with hematologic malignancy
por: Langerbeins, Petra, et al.
Publicado: (2022)

What Can Systems Theory of Networks Offer to Biology?
por: Rajapakse, Indika, et al.
Publicado: (2012)

CAR-NK cell therapy for hematological malignancies: recent updates from ASH 2022
por: Huang, Ruihao, et al.
Publicado: (2023)

Back to the Future: What Learning Communities Offer to Medical Education
por: Osterberg, Lars G., et al.
Publicado: (2016)

Benefits and challenges perceived by patients with cancer when offered a nurse navigator; a qualitative study
por: Thygesen, Marianne Kirstine, et al.
Publicado: (2010)

Ophthalmology at the Forefront of Big Data Integration in Medicine: Insights from the IRIS Registry Database
por: Knapp, Austen N., et al.
Publicado: (2023)

Tales from the Jazz ASH: highlights from the 2013 American Society of Haematology meeting
por: Mazzarella, Luca
Publicado: (2014)

Do point-of-care tests (POCTs) offer a new paradigm for the management of patients with influenza?
por: Dickson, Elizabeth M, et al.
Publicado: (2020)

Treatment and Prevention Strategies for Patients with Gynecological Malignancies During the COVID-19 Pandemic
por: Yang, Jiang, et al.
Publicado: (2020)

CDK9 INHIBITORS: a promising combination partner in the treatment of hematological malignancies
por: Morillo, Daniel, et al.
Publicado: (2023)

Public Engagement with Biotechnologies Offers Lessons for the Governance of Geoengineering Research and Beyond
por: Stilgoe, Jack, et al.
Publicado: (2013)

Microbiology Education and Infection Control Competency: Offering a New Perspective
por: Cox, Jennifer L., et al.
Publicado: (2018)

Why and how does light therapy offer neuroprotection in Parkinson's disease?
por: Mitrofanis, John
Publicado: (2017)

COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study
por: Martínez-López, Joaquín, et al.
Publicado: (2023)

Report on the 56th ASH Annual Meeting, San Francisco, 4–9 December 2014
por: Agazzi, Alberto
Publicado: (2015)

Hematological Malignancy Patients, COVID-19, and Favipiravir
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

The outcome of COVID-19 in patients with hematological malignancy
por: Tığlıoğlu, Pınar, et al.
Publicado: (2021)

Novel agents and regimens for hematological malignancies: recent updates from 2020 ASH annual meeting
por: Hou, Jing-Zhou, et al.
Publicado: (2021)

Novel cellular immunotherapies for hematological malignancies: recent updates from the 2021 ASH annual meeting
por: Wang, Ji-nuo, et al.
Publicado: (2022)

Targeting TIM-3 for hematological malignancy: latest updates from the 2022 ASH annual meeting
por: Tan, Jiaxiong, et al.
Publicado: (2023)

Clinical insights into hematologic malignancies and comparative analysis of molecular signatures of acute myeloid leukemia in different ethnicities using an artificial intelligence offering
por: Snowdon, Jane L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_04a48pjghbtub8hlp8g71s3g7m